Rapid immune reconstitution and complete donor chimerism after non-myeloablative allogeneic peripheral blood stem cell transplantation (NMSCT) in pediatric patients (PTS) with malignancy

被引：0
|
作者：
Fry, TJ
Rager, A
Hakim, F
Love, C
Layton, P
Fowler, D
Bishop, MR
Gress, R
Mackall, CL
Wayne, AS
机构：
[1] NCI, Pediat Oncol Branch, NIH, Bethesda, MD USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.251
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
230
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [21] Non-myeloablative allogeneic hematopoietic stem cell transplantation (SCT) with pre-transplant targeted immune depletion results in rapid full donor engraftment in pediatric patients with malignancy.
    Fry, TJ
    Salzman, TC
    Hakim, F
    Love, C
    Layton, P
    Gress, R
    Fowler, D
    Bishop, MR
    Mackall, CL
    Wayne, AS
    BLOOD, 2005, 106 (11) : 1022A - 1023A
  • [22] Donor cell leukemia after non-myeloablative allogeneic stem cell transplantation:: A single institution experience
    Ruiz-Arguelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Garces-Eisele, Javier
    Ruiz-Arguelles, Alejandro
    Perez-Romano, Beatriz
    Reyes-Nunez, Virginia
    LEUKEMIA & LYMPHOMA, 2006, 47 (09) : 1952 - 1955
  • [23] Kinetics of engraftment post non-myeloablative stem cell transplantation (full donor chimerism).
    Pugatsch, T
    Aker, M
    Shapira, M
    Slavin, S
    Or, R
    BLOOD, 2000, 96 (11) : 172A - 172A
  • [24] Chimerism analysis in peripheral blood buffy coat and T-cell fractions after non-myeloablative allogeneic peripheral blood stem cell transplant (PBSCT).
    Theil, K
    Warshawsky, I
    Tubbs, R
    Shadrach, B
    Serafino, S
    Cerankosky, L
    Johnston, G
    Rybicki, L
    Kuczkowski, E
    Jarvis, J
    Curtis, J
    Serafin, M
    Sands, K
    Bolwell, BJ
    BLOOD, 2001, 98 (11) : 188A - 189A
  • [25] Successful donor chimerism following unrelated donor stem cell transplantation for α-thalassemia after a non-myeloablative preparative regimen
    O'Brien, TA
    Wagner, JE
    Abel, S
    Ramsay, NKC
    Baker, KS
    PEDIATRIC RESEARCH, 2003, 53 (04) : 302A - 302A
  • [26] A combination of tacrolimus and mycofenolat mofetil after non-myeloablative unrelated matched donor allogeneic blood stem cell transplantation
    Zohren, F.
    Fenk, R.
    Graef, T.
    Czibere, A.
    Pape, H.
    Safaian, N.
    Kondakci, M.
    Germing, U.
    Haas, R.
    Kobbe, G.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S90 - S90
  • [27] Non-myeloablative allogeneic stem cell transplantation in 154 patients (pts) with chronic myeloid leukaemia (CML)
    Benakli, Malek
    Hamladji, Rose-Marie
    Nacer, Redhouane Ahmed
    Talbi, Amina
    Mehdid, Farih
    Belhadj, Rachida
    Rahmoune, Nadia
    BLOOD, 2007, 110 (11) : 321B - 321B
  • [28] Incidence and outcome of thrombotic microangiopathy after allogeneic peripheral blood stem cell transplantation with non-myeloablative conditioning compared with myeloablative conditioning
    Willems, E
    Baron, F
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 : S46 - S46
  • [29] T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT)
    Sobecks, R
    Theil, K
    Rybicki, L
    Kuczkowski, E
    Warshawsky, I
    Tubbs, R
    Kalaycio, M
    Pohlman, B
    Andresen, S
    Bolwell, BJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 41 - 42
  • [30] Engraftment of allogeneic T-cell depleted peripheral blood stem cell transplantation after non-myeloablative conditioning regiment
    Kreiter, S
    Schuler, M
    Kolbe, K
    Després, D
    Huber, C
    Derigs, HG
    BONE MARROW TRANSPLANTATION, 1999, 23 : S22 - S22
12345